1150 ATG-101, a tetravalent PD-L1×4–1BB BsAb, demonstrates potentin vivoanti-tumor efficacy in ICI-resistant or refectory mouse tumor models
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details